Anthony Pare's most recent trade in T2 Biosystems Inc was a trade of 9,620 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on March 17, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| T2 Biosystems Inc | Anthony Pare | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.84 per share. | 17 Mar 2021 | 9,620 | 31,612 (0%) | 0% | 1.8 | 17,701 | Common Stock |
| T2 Biosystems Inc | Anthony Pare | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2021 | 17,500 | 35,000 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Anthony Pare | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2021 | 17,500 | 41,232 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Anthony Pare | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 505,464 | 505,464 | - | - | Restricted Stock Units |